FindTrial
Sign In

STUDY OF CORRELATION BETWEEN MARKERS OF COAGULATION AND CLINICAL SEVERITY IN COVID 19

A STUDY OF COAGULATION MARKERS AND THEIR CORRELATION WITH CLINICAL SEVERITY IN COVID 19 ILNESS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029984
Enrollment
100
Registered
2020-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Smt NHL Municipal Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inpatients in General Medicine with a established diagnosis of COVID 19 infection( Laboratory confirmed ) Patients with abnormal coagulation markers Patients of age >18 years

Exclusion criteria

Exclusion criteria: Patients with proven others causes of coagulopathy - VTE, DVT, Recent Surgery/Trauma, Pregnancy, Cancer Patients already on anticoagulant therapy

Design outcomes

Primary

MeasureTime frame
In-hospital stay (Duration and Type of stay: ICU or Ward) Timepoint: At Baseline, Every 3rd Day till Discharge/Death—

Secondary

MeasureTime frame
Morbidity (PE, DVT,Stroke,etc) Mortality Timepoint: At Baseline, Every 3rd Day till Discharge/Death—

Countries

India

Contacts

Public ContactDR PALTIAL PALAT

Smt NHL Municipal Medical College

akash.jani@gmail.com8460706921

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026